Mitogen‐Activated Protein Kinase‐Dependent and Protein Kinase C‐Dependent Pathways Link the m1 Muscarinic Receptor to β‐Amyloid Precursor Protein Secretion

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Neurochemistry

• Publication date

  1998-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.1998.71052094.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Alpha-secretase inhibition impairs Group I metabotropic glutamate receptor-mediated protein synthesis, long-term potentiation and long-term depression

  2024cites this paper
• Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.

  2023cites this paper
• Long‐term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis

  2022cites this paper
• M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?

  2020cites this paper
• An adenoviral vector encoded with the GPx-1 gene attenuates memory impairments induced by β-amyloid (1-42) in GPx-1 KO mice via activation of M1 mAChR-mediated signalling

  2020cites this paper
• The Effect of Cumulative Anticholinergic Use on the Cognitive Function of Older Adults. Results from the Personality and Total Health (PATH) Through Life Study.

  2020cites this paper
• Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use

  2020cites this paper
• Therapeutic Potential of Multifunctional Tacrine Analogues

  2019cites this paper
• Constipation in Tg2576 mice model for Alzheimer’s disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response

  2019cites this paper
• Potential Treatment Strategies for Dementia With Pharmacological and Nonpharmacological Interventions

  2019cites this paper
• Promising horizon to alleviate Alzeheimer's disease pathological hallmarks via inhibiting mTOR signaling pathway: A new application for a commonplace analgesic.

  2018cites this paper
• Ginsenoside Rd promotes non‐amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha

  2017cites this paper
• Xanomeline derivative EUK1001 attenuates Alzheimer's disease pathology in a triple transgenic mouse model.

  2017cites this paper
• Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer's disease.

  2017cites this paper
• Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo

  2016cites this paper
• Long-term trihexyphenidyl exposure alters neuroimmune response and inflammation in aging rat: relevance to age and Alzheimer’s disease

  2016cites this paper
• Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study

  2015cites this paper
• Pharmacological effects of Ibuprofen on learning and memory, muscarinic receptors gene expression and APP isoforms level in pre-frontal cortex of AlCl3-induced toxicity mouse model

  2015cites this paper
• M1 muscarinic acetylcholine receptor in Alzheimer’s disease

  2014cites this paper
• α7 nicotinic acetylcholine receptors at the glutamatergic synapse

  2014cites this paper
• Activation of M1 mAChRs by lesatropane rescues glutamate neurotoxicity in PC12 cells via PKC-mediated phosphorylation of ERK1/2.

  2013cites this paper
• Noradrenergic Sympathetic Sprouting and Cholinergic Reinnervation Maintains Non-Amyloidogenic Processing of AβPP

  2013cites this paper
• Chronic Anticholinergic Use and the Aging Brain

  2013cites this paper
• Activation of M 1 mAChRs by lesatropane rescues glutamate neurotoxicity in PC 12 cells via PKC-mediated phosphorylation of ERK 1 / 2

  2013cites this paper
• Long‐term anticholinergic use and the aging brain

  2013cites this paper
• The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease

  2012cites this paper
• Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease

  2012cites this paper
• Huprine X and Huperzine A Improve Cognition and Regulate Some Neurochemical Processes Related with Alzheimer’s Disease in Triple Transgenic Mice (3xTg-AD)

  2012cites this paper
• Huperzine a alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice

  2012cites this paper
• Bilobalide regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway.

  2011cites this paper
• Intracellular distribution of functional M1‐muscarinic acetylcholine receptors in N1E‐115 neuroblastoma cells

  2011cites this paper
• Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study

  2011cites this paper
• Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans

  2011cites this paper
• Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline.

  2011cites this paper
• Use of anticholinergics and the risk of cognitive impairment in an African American population

  2010cites this paper
• The Purinergic Receptor P2X7 Triggers α-Secretase-dependent Processing of the Amyloid Precursor Protein*

  2010cites this paper
• Investigational Medications for Treatment of Patients With Alzheimer Disease

  2010cites this paper
• Angiotensin II AT2 Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease*

  2009cites this paper
• Fustin flavonoid attenuates β‐amyloid (1–42)‐induced learning impairment

  2009cites this paper
• Effect of Novel Amino Acids and Dipeptides Substituted 3-Morpholino Arecoline Derivatives as Muscarinic Receptor 1 Agonists in Alzheimer’s Dementia Models

  2009cites this paper
• Dominant Negative AT2 Receptor Oligomers Induce G-protein Arrest and Symptoms of Neurodegeneration*

  2009cites this paper
• The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer.

  2008cites this paper
• Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase

  2008cites this paper
• Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease

  2008cites this paper
• Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.

  2008cites this paper
• Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.

  2008cites this paper
• Muscarinic acetylcholine receptors as CNS drug targets.

  2008cites this paper
• M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease

  2007cites this paper
• Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.

  2007cites this paper
• Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects

  2007cites this paper
• Involvement of M1-muscarinic acetylcholine receptors, protein kinase C and mitogen-activated protein kinase in the effect of huperzine A on secretory amyloid precursor protein-&agr;

  2007cites this paper
• Muscarinic Acetylcholine Receptors in the Central Nervous System: Structure, Function, and Pharmacology

  2007cites this paper
• M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease

  2007cites this paper
• Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib and Abl/Lyn inhibitor INNO‐406 in newly established K562 variants with BCR‐ABL gene amplification

  2007influential citation
• Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.

  2006cites this paper
• Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer‐like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein

  2006cites this paper
• The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease

  2006cites this paper
• Activation of muscarinic M4 receptor augments NGF-induced pro-survival Akt signaling in PC12 cells.

  2006cites this paper
• M1 receptors play a central role in modulating AD-like pathology in transgenic mice.

  2006cites this paper
• Therapeutic Uses of Cholinesterase Inhibitors in Neurodegenerative Diseases

  2006cites this paper
• Effects of huperzine A on amyloid precursor protein processing and β‐amyloid generation in human embryonic kidney 293 APP Swedish mutant cells

  2006cites this paper
• Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling

  2005cites this paper
• Targeting acetylcholinesterase and butyrylcholinesterase in dementia.

  2005cites this paper
• Short‐term interleukin‐1β increases the release of secreted APPα via MEK1/2‐dependent and JNK‐dependent α‐secretase cleavage in neuroglioma U251 cells

  2005cites this paper
• Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

  2005cites this paper
• M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway.

  2004cites this paper
• Acetylcholinesterase inhibitors: novel activities of old molecules.

  2004cites this paper
• Acetylcholinesterase and Its Inhibition in Alzheimer Disease

  2004cites this paper
• The pharmacology of amyloid precursor protein processing.

  2003cites this paper
• The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

  2003cites this paper
• Altered hippocampal muscarinic receptors in acetylcholinesterase‐deficient mice

  2003cites this paper
• Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction.

  2003cites this paper
• Molecular and Cellular Basis for Anti-Amyloid Therapy in Alzheimer Disease

  2003cites this paper
• Role of protein kinase Cα in the regulated secretion of the amyloid precursor protein

  2003cites this paper
• Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo.

  2003cites this paper
• Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors

  2003cites this paper
• Effect of PPF and ALCAR on the induction of NGF- and p75-mRNA and on APP processing in Tg2576 brain.

  2003cites this paper
• Impact of muscarinic agonists for successful therapy of Alzheimer's disease.

  2002cites this paper
• Neurohormonal Signalling Pathways and the Regulation of Alzheimer β-Amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease

  2002cites this paper
• AF150(S) and AF267B

  2002cites this paper
• Implications of Amyloid Precursor Protein and Subsequent β‐Amyloid Production to the Pharmacotherapy of Alzheimer's Disease

  2002cites this paper
• Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?

  2002cites this paper
• Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease.

  2002cites this paper
• Quinuclidinone O-Alkynyloximes with muscarinic agonist activity.

  2002cites this paper
• Intracellular A-beta amyloid, A sign for worse things to come?

  2002cites this paper
• Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C.

  2002cites this paper
• The M1 Receptor Is Required for Muscarinic Activation of Mitogen-activated Protein (MAP) Kinase in Murine Cerebral Cortical Neurons*

  2001cites this paper
• Dishevelled Regulates the Metabolism of Amyloid Precursor Protein via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun Terminal Kinase

  2001cites this paper
• Reactive oxygen species regulate signaling pathways induced by M1 muscarinic receptors in PC12M1 cells

  2001influential citation
• Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists.

  2001cites this paper
• Activation of mitogen‐activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol

  2001influential citation
• 3 Intracellular pathways involved in TNF-α and superoxide anion release by A β ( 1-42 )-stimulated primary human macrophages

  2001influential citation
• M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices.

  2001cites this paper
• A CalDAG-GEFI/Rap1/B-Raf Cassette Couples M1Muscarinic Acetylcholine Receptors to the Activation of ERK1/2*

  2001cites this paper
• Zn2+‐induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells

  2001cites this paper
• The β-Amyloid Precursor Protein and its Derivatives: From Biology to Learning and Memory Processes

  2000cites this paper
• Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

  2000cites this paper
• Regulation of alzheimer beta-amyloid precursor trafficking and metabolism.

  2000cites this paper
• Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.

  2000cites this paper
• Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.

  2000cites this paper